CEACAM5 and colorectal carcinoma: The study showed no statistically significant differences in serum CEA levels between the group of patients with CA-CRC as compared to the group of patients with sporadic cancer (21.1 ± 14.9 ng/mL vs. 22.6 ± 14.6 ng/mL; p = 0.363; Figure 3).